MTOR and cancer: The PI3K/AKT pathway acts as a positive regulator of the mTOR pathway, which serves as a negative regulator of autophagy in cancer cells [24], so that disruption of the PI3K/AKT/mTOR/p70S6K pathway by anticancer agents induces autophagy.